PDK4 and hepatocellular carcinoma: According to their claims, enhanced glycolysis is associated with CD133 ( +) stem-like features, and metabolic reprogramming with miR-122 or PDK4 may be a cutting-edge treatment option for hepatocellular carcinoma [91].